US Bancorp DE lowered its stake in XPeng Inc. (NYSE:XPEV – Free Report) by 10.8% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 65,959 shares of the company’s stock after selling 7,998 shares during the period. US Bancorp DE’s holdings in XPeng were worth $780,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Avior Wealth Management LLC grew its stake in shares of XPeng by 1,215.2% in the 4th quarter. Avior Wealth Management LLC now owns 2,775 shares of the company’s stock worth $33,000 after buying an additional 2,564 shares during the last quarter. Golden State Wealth Management LLC purchased a new stake in shares of XPeng in the 4th quarter worth approximately $41,000. Compagnie Lombard Odier SCmA grew its stake in shares of XPeng by 1,703.3% in the 4th quarter. Compagnie Lombard Odier SCmA now owns 8,115 shares of the company’s stock worth $96,000 after buying an additional 7,665 shares during the last quarter. Venturi Wealth Management LLC purchased a new stake in shares of XPeng in the 3rd quarter worth approximately $110,000. Finally, Atomi Financial Group Inc. grew its stake in shares of XPeng by 44.9% in the 4th quarter. Atomi Financial Group Inc. now owns 15,346 shares of the company’s stock worth $181,000 after buying an additional 4,758 shares during the last quarter. Hedge funds and other institutional investors own 21.09% of the company’s stock.
Analysts Set New Price Targets
Several brokerages have commented on XPEV. UBS Group upgraded XPeng from a “sell” rating to a “neutral” rating and increased their target price for the company from $8.80 to $18.00 in a research note on Monday, February 24th. The Goldman Sachs Group downgraded XPeng from a “buy” rating to a “neutral” rating and set a $12.50 target price on the stock. in a research note on Thursday, November 21st. Citigroup upgraded XPeng from a “neutral” rating to a “buy” rating and increased their target price for the company from $13.70 to $29.00 in a research note on Monday. Sanford C. Bernstein increased their target price on XPeng from $9.00 to $14.00 and gave the company a “market perform” rating in a research note on Wednesday, November 20th. Finally, China Renaissance upgraded XPeng from a “hold” rating to a “buy” rating and set a $16.70 target price on the stock in a research note on Friday, November 22nd. Four investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $15.63.
XPeng Stock Performance
XPEV stock opened at $22.90 on Tuesday. The company has a market cap of $21.57 billion, a P/E ratio of -26.32 and a beta of 2.68. XPeng Inc. has a 1 year low of $6.55 and a 1 year high of $23.98. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.37 and a quick ratio of 1.18. The stock’s fifty day moving average price is $16.15 and its 200-day moving average price is $13.08.
XPeng Profile
XPeng Inc designs, develops, manufactures, and markets smart electric vehicles (EVs) in the People's Republic of China. It offers SUVs under the G3, G3i, and G9 names; four-door sports sedans under the P7 and P7i names; and family sedans under the P5 name. The company also provides sales contracts, super charging, maintenance, technical support, auto financing, insurance, technology support, ride-hailing, automotive loan referral, and other services, as well as vehicle leasing and insurance agency services.
Featured Articles
- Five stocks we like better than XPeng
- How Investors Can Find the Best Cheap Dividend Stocks
- How to Protect Your Portfolio When Inflation Is Rising
- Earnings Per Share Calculator: How to Calculate EPS
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- How Can Investors Benefit From After-Hours Trading
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Want to see what other hedge funds are holding XPEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for XPeng Inc. (NYSE:XPEV – Free Report).
Receive News & Ratings for XPeng Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XPeng and related companies with MarketBeat.com's FREE daily email newsletter.